{"id":"badc401f-0c44-458a-8c9d-91d8dddcfd4f","name":"Cognixion","slug":"cognixion","description":"Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality. Its [Cognixion ONE Axon-R](/models/cognixion-ar-bci-headset) headset combines BCI, AI, and AR for communication in patients with ALS and severe motor impairment. FDA Breakthrough Device Designation (May 2023). Clinical trial launched for late-stage ALS. $25M raised to date. Named Wearable & Implantable Technology of the Year at MedTech World 2026.","status":"private","founded":0,"hq":"Santa Barbara, California, USA","hqLat":34.4221319,"hqLng":-119.702667,"hqGeocodedAt":"2026-08-23T21:32:01.303Z","hqAddress":null,"hqPrecision":null,"website":"https://www.cognixion.com","fundingTotal":"25000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":"[{\"url\":\"https://www.cognixion.com/\",\"title\":\"Cognixion — AR-BCI headset for accessible communication\",\"sourceName\":\"Cognixion (official)\"}]","keyFacts":[{"label":"Headquarters","value":"Santa Barbara, California, USA"},null,{"label":"Status","value":"private"},{"label":"Type","value":"hardware"},{"label":"CEO & Founder","value":"Andreas Forsland (since 2015)"},{"label":"CTO & Co-Founder","value":"Chris Ullrich (also clinical trial PI)"},{"label":"HQ","value":"Santa Ana, California"},{"label":"Total Funding","value":"~$25M (Seed $12M Nov 2021 + extensions)"},{"label":"Key Investors","value":"Prime Movers Lab, Amazon Alexa Fund, Northwell Health, Verizon Forward for Good, Volta Circle"},{"label":"Product","value":"Cognixion ONE Axon-R — non-invasive wireless BCI headset with integrated AR display (EEG + AI/LLM)"},{"label":"FDA Status","value":"Breakthrough Device designation (May 2023); CMS accreditation (May 2023)"},{"label":"Clinical Trials","value":"NCT06810219 (ALS, 2025), NCT07209943 (ALS/stroke/TBI + Vision Pro, Oct 2025)"},{"label":"Collaborators","value":"Johns Hopkins, Mass General, Northwell Health, Memorial Hermann, Veterans Health Administration"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:26:45.318Z","updatedAt":"2026-08-21T22:31:41.388Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/cognixion","url":"https://registry.deploy.report/companies/cognixion","name":"Cognixion","description":"Cognixion is a Santa Barbara-based neurotechnology company developing non-invasive brain-computer interface technology integrated with augmented reality. Its [Cognixion ONE Axon-R](/models/cognixion-ar-bci-headset) headset combines BCI, AI, and AR for communication in patients with ALS and severe motor impairment. FDA Breakthrough Device Designation (May 2023). Clinical trial launched for late-stage ALS. $25M raised to date. Named Wearable & Implantable Technology of the Year at MedTech World 2026.","identifier":"badc401f-0c44-458a-8c9d-91d8dddcfd4f","address":"Santa Barbara, California, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["primary-company-ir"]}}}